Literature DB >> 12513964

Symptom control in patients with locally recurrent rectal cancer.

Thomas J Miner1, David P Jaques, Philip B Paty, Jose G Guillem, W Douglas Wong.   

Abstract

BACKGROUND: Although resection of locally recurrent rectal cancer has been associated with improved survival, clinical outcomes after such repeat surgery have been incompletely characterized.
METHODS: From 1997 to 1999, 105 consecutive patients requiring repeat surgery for locally recurrent rectal cancer were identified. Patients were observed for a minimum of 2 years or until death.
RESULTS: An operation was performed with palliative intent in 23% of patients. Before repeat surgery, 79% of the palliative-intent patients had symptoms: 21% bleeding, 42% obstruction, and 21% pain. After repeat surgery with palliative intent, improvement was noted in 40% with bleeding, 70% with obstruction, and 20% with pain. Additional or recurrent symptoms were noted in 87% during follow-up. Seventy-seven percent of patients had an operation with nonpalliative intent. Before repeat surgery, 57% of nonpalliative patients had symptoms, with 32% experiencing bleeding, 11% obstruction, and 19% pain. After repeat surgery with nonpalliative intent, initial improvement was noted in 88% with bleeding, 78% with obstruction, and 40% with pain. During follow-up, symptoms arose in 37% of the initially asymptomatic patients, and additional or recurrent symptoms were seen in 63% of those previously symptomatic.
CONCLUSIONS: Although symptomatic relief is associated with repeat surgery, the recurrence or development of alternate symptoms makes a completely asymptomatic clinical course uncommon.

Entities:  

Mesh:

Year:  2003        PMID: 12513964     DOI: 10.1245/aso.2003.03.040

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

1.  [Locally recurrent rectal carcinoma].

Authors:  Th Lehnert; M Golling; J Buchholz
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

2.  Factors associated with the location of local rectal cancer recurrence and predictors of survival.

Authors:  Peng Du; John P Burke; Wisam Khoury; Ian C Lavery; Ravi P Kiran; Feza H Remzi; David W Dietz
Journal:  Int J Colorectal Dis       Date:  2016-02-10       Impact factor: 2.571

Review 3.  Current role of surgical therapy in gastric cancer.

Authors:  Ryan Swan; Thomas J Miner
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

4.  Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy.

Authors:  Thomas J Miner; Jinru Shia; David P Jaques; David S Klimstra; Murray F Brennan; Daniel G Coit
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer.

Authors:  Y Nancy You; Halim Habiba; George J Chang; Miguel A Rodriguez-bigas; John M Skibber
Journal:  Ann Surg Oncol       Date:  2010-12-04       Impact factor: 5.344

6.  Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: a single unit experience, 1994-2003.

Authors:  Antonio Chiappa; Roberto Biffi; Andrew P Zbar; Fabrizio Luca; Cristiano Crotti; Emilio Bertani; Francesca Biella; Giulia Zampino; Roberto Orecchia; Nicola Fazio; Marco Venturino; Cristiano Crosta; Gian Carlo Pruneri; Carmine Grassi; Bruno Andreoni
Journal:  Int J Colorectal Dis       Date:  2004-12-16       Impact factor: 2.571

7.  A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer.

Authors:  Thomas J Miner; Murray F Brennan; David P Jaques
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

Review 8.  Intentionally curative treatment of locally recurrent rectal cancer: a systematic review.

Authors:  Pieter J Tanis; Annemiek Doeksen; J Jan B van Lanschot
Journal:  Can J Surg       Date:  2013-04       Impact factor: 2.089

Review 9.  Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options.

Authors:  P A Georgiou; P P Tekkis; G Brown
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.